New every week: podcasts, research & peptide news •New every week: podcasts, research & peptide news •New every week: podcasts, research & peptide news •New every week: podcasts, research & peptide news •New every week: podcasts, research & peptide news •New every week: podcasts, research & peptide news •New every week: podcasts, research & peptide news •New every week: podcasts, research & peptide news •
← All podcastsThe Peter Attia Drive cover

The Peter Attia Drive · 12 Nov 2026 · 1 h 48 min

The GLP-1 era: what comes after semaglutide?

Listen on Spotify

Our summary

A deep conversation on how incretin-based peptides changed obesity research, and why triple agonists like retatrutide are drawing so much attention in current trials.

Key points

Exclusive for PeptideNews readers

Get exclusive access to a trusted source of RUO peptides

As a research site, we can give you access to a supplier that meets the standards we write about.

  • 60-day money-back guarantee
  • Temperature-protected shipping
  • Produced in the EU
  • Third-party lab tested
  • Traceable testing
  • 99% purity
  • Delivery in 2–5 days across the EU

For research use only (RUO). Not for human consumption.